ANATOMY 1 Name of the Department: Department ... - Biomeedikum

More documents

Recommendations

Info

SECTION I: APPENDIXES 26. Cardiovasc Res., Lipid peroxidation, arachidonic acid and products of the lipoxygenase pathway in ischemic preconditioning of rat heart,1998,37,66-75,Starkopf J, Andreasen TV, Bugge E, Ytrehus K. 27. Neurobiology of Aging. Regulation of GTPase and adenylate cyclase by amyloid-b peptides,1998, 19, 48. Langel, Ü., Soomets, U., Mahlapuu, R., Karelson, E., Zilmer, M., Zorko, M. 28. Br J Pharmacol., Structural determinants for binding to CGRP receptors expressed by human SK- N-MC and Col 29 cells: studies with chimeric and other peptides.1998, 124, 1659-1666, Poyner D.R., Soomets U., Howitt S.G., Langel, Ü. 29. Proceedings of 15th American Peptide Symposia. Intracellular third loop of galanin receptor as Gprotein interaction site,1998 (in press), Soomets U.,Langel Ü. 30. Nature Biotechnology. Cell penetrating PNA antisense oligonucleotides modify galaninergic pain transmission in vivo. 1998, 16, 857-861. Pooga M., Hällbrink M., Soomets U., Valkna A., Saar K., Rezaei K., Kahl U., Hao J.-X., Xu X.-J., Wiesenfeld-Hallin Z., Bartfai T. and Langel Ü. 31. Arch. Biochem. Biophys. Differential regulation of GTPase activity by mastoparan and galparan. 1998, 349,2, 321-328, Zorko M., Pooga M., Saar K., Rezaei K., Langel, Ü. 32. J. Peptide Res. Novel galanin receptor ligands. 1998,51, 65-74, Pooga M., Juréus A., Rezaei K., Hasanvan H., Saar K., Kask K., Kjellén P., Land T., Halonen J., Mäeorg U., Uri A., Solyom S., Bartfai T., and Langel Ü. 33. Cell Calcium. Biochemical mechanisms of calcium mobilisation induced by mastoparan and chimeric hormone-mastoparan constructs. 1998, 24, 27-34, Longland C.L, Mezna M, Langel Ü, Hällbrink M, Soomets U, Wheatley M, Michelangeli F, Howl J. 34. J. Neurosci., Galanin modulation of seizures and seizure modulation of hippocampal galanin in animal models of status epilepticus. 1998,18,23,10070-7., Mazarati, A. M., Liu, H., Soomets, U., Sankar, R., Shin, D., Katsumori, H., Langel, Ü., Wasterlain, C. G. 35. Current Topics in Peptide and Protein Res. From galanin and mastoparan to galparan and transportan. 1998, 2, 83-113, Soomets U., Hällbrink M., Zorko M., Langel Ü. 36. Acta.Chem.Slov. Structural features of amphipathic peptides required for the activation of Gproteins. 1998, 45,27-34, Bavec A., Soomets U., Langel Ü., Zorko M. 37. Neuropeptides. Galaninrergic signalling and adenylate cyclase. 1998, 32, 197-210, Karelson E, Langel Ü. 38. Biochemical Soc. Transactions. Review article. The role of the third cytoplasmic loop in signal transduction by galanin receptors, 1997, 25, 1036-1040, Saar, K., Valkna, A., Soomets U., Rezai, K., Zilmer, M., Langel, Ü. 39. Proceedings of the 24 th Symposium of European peptide Society. Galanin receptor G-protein interaction sites as targets for drug developments. Peptides 1998: Eds. R. Ramage, R. Epton, 1997, 67-70, Rezaei, K, Valkna, A., Saar, K.,Bartfai, T, Langel, Ü. 40. FASEB J. Chimeric strategy for the rational design of bioactive analogs of small peptide hormones, 1997,11 (7), 582-590, Howl, J., Parslow, R.A., Langel, Ü., Hawtin, S.R., Valkna, A., Yarwood, N.J., Saar, K., and Wheatley, M. 41. European Journal of Neurology. Lead-induced excessive lipid peroxidation and changes in local cerebral blood flow in rabbit brain.1997,4,390-396, Linnamägi,Ü, Zilmer,K, Zilmer, M, Kaasik,A.-E. 42. Acta Neurol Scand. Changes of sympatho-adrenal and hupothalamo-pituitary-adrenocortical system in patents with head injury.1997,96,52-58, Kõiv, L, Merisalu, E, Zilmer,K, Tomberg, T, Kaasik,A.-E. 43. Acta Chemica Scand., Solubilisation of Na,K-ATPase with amphiphilic peptide PD1, 1997,51,403- 406, Soomets, U, Kairane, C, Zilmer, M, Langel, Ü. 44. Clinica Chimica Acta. The evidence of oxidative stress in cardiac surgery and septic patients- comparative study. 1997, 262,77-88,Starkopf, J, Kokk, K, Zilmer, M, Talvik, R, Samarütel, J. 45. Quintessenz. Scientific portrait of xylitol. 1997,1,24-28, Zilmer, M, Kokassaar, U. 46. Cardiovasc Res. Preischemic bradykinin and ischemic preconditioning in functional and metabolic recovery of globally ischemic rat heart,1997, 33,63-70, Starkopf, J,Ytrehus, Y. 47. Pharmacology & Toxicology. Antioxidative capacity of pinoline in three in vitro assay systems, 1997, 80, Supplement I, p.41, Pähkla, R, Zilmer, M, Kullisaar, T, Rägo, L. 48. Regulatory Peptides. A galanin-mastoparan chimeric peptide activates the Na,K-ATPase and and reverses its inhibition by ouabain,1996, 62,47-52, Langel, Ü., Pooga, M., Kairane, C., Zilmer, M., Bartfai, T. 49. J of Hypertension. Oxidative stress and hyperinsulinaemia in essential hypertension: different facets of in increased risk, 1996,14, 3,407-410, Parik, T, Allikmets, K, Teesalu, R, Zilmer, M. 50. J of Human Hypertension. Effects of isradipine treatment on oxidative stress markers in patients with essential hypertension, 1996,10, 53-55, Parik, T, Allikmets, K, Zilmer, K, Vihalemm, T, Kullisaar, Teesalu, R, Zilmer, M. 34
BIOCHEMISTRY 51. J Cardiovascular risk. Evidence for oxidative stress in essential hypertension: perspective for antioxidant therapy, 1996,3,49-53, Parik, T, Allikmets, K, Teesalu, R, Zilmer, M. 52. Meth Find Exp Clin Pharmacol. Autoradiographic localization of [3H] pinoline binding sites in mouse tissues, 1996,18, 359-366, Pähkla, R, Masso, R, Zilmer, M, Rägo, L, Airaksen, M, M. 53. Acta Medica Baltica. Effects of nifedipine treatment on oxidative stress markers in hypertensive patients, 1996, 3(2), 140-144, Parik, T, Allikmets,K, Teesalu,R, Zilmer, M. 54. Acta Pediatrica. Markers of oxidative stress before and after exchange transfusion for neonatal sepsis,1996, 85,10,1244-1246, Kokk T,Talvik,R, Zilmer,M, Kütt,E, Talvik,T. 55. Neurochemistry. Investigations of some natural peptides and their synthetic derivatives using brain Na,K-ATPase, 1996, 13, 3, 223-227, Kairane, C, Tähepõld, L, Langel, Ü, Sillard, R, Zilmer, M. (in Russian). 56. Scandinavian J Rheumatology. Nutrition in Prevention of Osteoporosis. 1996, 25,81-82, Teesalu, S, Vihalemm, T, Vaasa, I-O. 57. 5 articles are submitted in 2001. ARTICLES IN ANOTHER PEER REVIEWED ISSUES 1. Estonian Pharmacist. Alcohol. 2000,1,15-20, Kokassaar, U, Vihalemm, T, Zilmer, M. (in Estonia). 2. Scandinavian J of Nutrition. The consumption of goat’s milk yoghurt fermented with special lactobacillus strains may improve the human antioxidative status. 2000, 44, (Supplement 37), S94, Songisepp, E, Kullisaar, T, Zilmer, K, Mikelsaar, M, Zilmer,M. 3. Estonian Pharmacist. Bouillon (scientific background). 1999,4, 14-17, Kokassaar, U, Vihalemm, T, Zilmer, M. (in Estonia). 4. Estonian Pharmacist. Juice, nectar, juice beverage (scientific background).1999,3, 8-11, Vihalemm, T, Kokassaar, U, Zilmer, M. (in Estonia). 5. Estonian Pharmacist. Mineral water. 1999,2,16-20, Vihalemm, T, Kokassaar, U, Zilmer, M. (in Estonia). 6. Estonian Pharmacist. Tea (Scientific background).1999,1,11-16, Kokassaar, U, Vihalemm, T, Zilmer, M. (in Estonia). 7. Estonian Parmacist. Cacao (Scientific background).1998,4,13-18, Kokassaar, U, Vihalemm, T, Zilmer, M. (in Estonia). 8. Estonian Parmacist. Coffee (Scientific background).1998,3, 11-15, Vihalemm, T, Kokassaar, U, Zilmer, M. (in Estonia). 9. Estonian Parmacist. Scientific background of popularity of fermented milk products. 1998,1, 16-20, Vihalemm, T, Kokassaar, U, Zilmer, M. (in Estonia). 10. Estonian Pharmacist. Could long-lasting alimentary iron overload have an impct on the parameters of oxidative stress? 1997, 54-55, Rehema, A, Zilmer, K, Vihalemm, T, Kullisaar, T, Zilmer, M. (in Estonian). 11. Estonian Pharmacist. Oxidative stress and damages of heart: possible preventive manipulations of myocard. 1997,67-68, Starrkopf, J. Valen, G, Vihalemm, T, Kullisaar, T, Kengsepp, A.-T. Kairane, C, Zilmer, K, Zilmer, M. (in Estonian). 12. Estonian Pharmacist. Testing of antioxidative capacity of saliva in healthy and parodontosis. 1997, 24-25, Kullisaar, T, Kengsepp, A.-T, Saag, M, Maksimov, S, Vihalemm, T, Zilmer, M. (in Estonian). 13. Estonian Pharmacist. Pinoline and melatonin: potent antioxidants. 1997, 47-48, Pähkla, R, Zilmer, M, Kullisaar, T, Rägo, L. (in Estonian). 14. Estonian Physician. Effect of isradipine on oxidative stress, 1997, (Supplement) 41-42, Parik, T., Allikmets, K., Teesalu, R., Zilmer M (in Estonian). 15. Estonian Parmacist. Milk. 1997,4, 15-18, Vihalemm, T, Kokassaar, U, Zilmer, M. (in Estonia). 16. Estonian Parmacist. Hirudotherapy in the past and future. 1997,2, 10-14, Kokassaar, U, Zilmer, M. (in Estonia). 17. Estonian Pharmacist. Food, nutrition and nutrients. VII, Food additives. 1997,1,13-16, Kokassaar, U, Vihalemm, T, Zilmer, M, (in Estonian). 18. Estonian Pharmacist. Food, nutrition and nutrients. VI, Water. 1996,3,17-21, Kokassaar, U, Vihalemm, T, Zilmer, M, (in Estonian). 19. Estonian Pharmacist. Chimeric peptides as basic molecules for disaining new drugs, 1996, 3, 8-10, Laidmäe, E, Karelson, E, Hindrikus, T, Zilmer, M, (in Estonian). 20. Estonian Pharmacist. Food, nutrition and nutrients. Vb, Bioelements in our food (II). 1996, 2,21-26, Kokassaar, U, Vihalemm, T, Zilmer, M, (in Estonian). 21. Estonian Pharmacist. Food, nutrition and nutrients. Va, Bioelements in our food (I). 1996, 1,11-16, Kokassaar, U, Vihalemm, T, Zilmer, M, (in Estonian). 22. Scient.Conf. “17th Estonian Chemistry Days”, Tartu, Dependence of brain adenylate cyclase activity on concentration of Rb + ja Cs + .1996,173-174. Rosenthal, K, Lember J, Karelson E. 35
Page 1 and 2: ANATOMY Name of the Department: Dep
Page 3 and 4: ANATOMY Weaknesses • Limited time
Page 5 and 6: ANATOMY To continue the integration
Page 7 and 8: ANATOMY been reduced from 6 CP to 5
Page 9 and 10: IV. TEACHING RESOURCES ANATOMY 9. I
Page 11 and 12: APPENDIX I-I Visits of the Departme
Page 13 and 14: APPENDIX I-VI Publications of the D
Page 15 and 16: PAPERS IN ESTONIAN JOURNALS ANATOMY
Page 17: APPENDIX I-VII Academic and adminis
Page 20 and 21: SECTION I: APPENDIXES societies: Mo
Page 23 and 24: BIOCHEMISTRY Name of Department: De
Page 25 and 26: BIOCHEMISTRY eliminated. Such alter
Page 27 and 28: BIOCHEMISTRY Biochemistry: resource
Page 29 and 30: APPENDIX I-II BIOCHEMISTRY Postgrad
Page 33: BIOCHEMISTRY 4. Dementia and Geriat
Page 40 and 41: SECTION I: APPENDIXES ship in acade
Page 42 and 43: SECTION I: SELF-EVALUATION 42 proac
Page 44 and 45: SECTION I: SELF-EVALUATION 44 the a
Page 46 and 47: SECTION I: SELF-EVALUATION 46 The f
Page 48 and 49: SECTION I: SELF-EVALUATION 48 macol
Page 50 and 51: SECTION I: APPENDIXES APPENDIX I-I
Page 52 and 53: SECTION I: APPENDIXES APPENDIX I-IV
Page 54 and 55: SECTION I: APPENDIXES 12. C.Löfber
Page 56 and 57: SECTION I: APPENDIXES 54. C.Löfber
Page 58 and 59: SECTION I: APPENDIXES 100. Kalda A.
Page 60 and 61: SECTION I: APPENDIXES 12. M. Otter.
Page 66 and 67: SECTION I: APPENDIXES Community 5th
Page 68 and 69: SECTION I: APPENDIXES Tartu as a ph
Page 71 and 72: PHYSIOLOGY Name of Department: Depa
Page 73 and 74: PHYSIOLOGY 3. Describe the strength
Page 75 and 76: PHYSIOLOGY students. According to t
Page 77 and 78: PHYSIOLOGY Physiology: resource eva
Page 79 and 80: PHYSIOLOGY 1999 Kersti Jagomägi, s
Page 83: PHYSIOLOGY 67. J.Kivastik, P.-H.Kin
Page 87 and 88:
APPENDIX I-VIII Curriculum Vitae of
Page 89 and 90:
PHYSIOLOGY meeting on physiology" 1
Page 91:
PHYSIOLOGY University of Kuopio;vis
Page 94 and 95:
SECTION I: SELF-EVALUATION ceptual
Page 96 and 97:
SECTION I: SELF-EVALUATION 96 stude
Page 98 and 99:
SECTION I: SELF-EVALUATION VI. FUTU
Page 100 and 101:
SECTION I: APPENDIXES APPENDIX I-I
Page 102 and 103:
SECTION I: APPENDIXES APPENDIX I-VI
Page 104 and 105:
SECTION I: APPENDIXES 2. Mikelsaar
Page 107:
APPENDIX I-VII Academic and adminis
Page 110 and 111:
SECTION I: APPENDIXES was supported
Page 113 and 114:
PATHOLOGICAL ANATOMY AND FORENSIC M
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
Page 123 and 124:
APPENDIX I-I PATHOLOGICAL ANATOMY A
Page 125 and 126:
Page 127:
Page 130 and 131:
SECTION I: APPENDIXES DRIKKIT, ILON
Page 132 and 133:
SECTION I: SELF-EVALUATION 2. How h
Page 134 and 135:
SECTION I: SELF-EVALUATION 8. Is th
Page 136 and 137:
Page 138 and 139:
SECTION I: APPENDIXES 1999 Argo Soo
Page 140 and 141:
SECTION I: APPENDIXES APPENDIX I-V
Page 142 and 143:
SECTION I: APPENDIXES 8. Harro J, S
Page 144 and 145:
SECTION I: APPENDIXES 98. Põlluste
Page 147:
Page 150 and 151:
SECTION I: APPENDIXES Nutritional S
Page 152 and 153:
SECTION I: APPENDIXES Economists Cu
Page 154 and 155:
SECTION I: SELF-EVALUATION • Biol
Page 156 and 157:
SECTION I: SELF-EVALUATION 156 The
Page 158 and 159:
SECTION I: SELF-EVALUATION 158 2. C
Page 160 and 161:
SECTION I: SELF-EVALUATION 160 2. T
Page 162 and 163:
SECTION I: SELF-EVALUATION II. EVAL
Page 164 and 165:
SECTION I: SELF-EVALUATION 164 Subj
Page 166 and 167:
Page 168 and 169:
SECTION I: APPENDIXES APPENDIX I-V
Page 170 and 171:
SECTION I: APPENDIXES 31. Waldmann
Page 173:
Page 176 and 177:
SECTION I: APPENDIXES partment of G
Page 178 and 179:
SECTION I: APPENDIXES arum (MSc) in
Page 180 and 181:
SECTION I: SELF-EVALUATION 180 1. T
Page 182 and 183:
SECTION I: SELF-EVALUATION 182 Duri
Page 184 and 185:
SECTION I: SELF-EVALUATION 184 2. B
Page 186 and 187:
Page 188 and 189:
SECTION I: APPENDIXES 19. Tiivel T.
Page 191 and 192:
APPENDIX I-VIII Curriculum Vitae of
Page 193 and 194:
IMMUNOLOGY Name of the Department:
Page 195 and 196:
IMMUNOLOGY equipped with English la
Page 197 and 198:
IMMUNOLOGY Immunology: resource eva
Page 199 and 200:
APPENDIX I-II IMMUNOLOGY Postgradua
Page 201 and 202:
IMMUNOLOGY 19. Juhela S, Hyöty H,
Page 203:
Page 206 and 207:
SECTION I: APPENDIXES Laboratory of
show all

ANATOMY 1 Name of the Department: Department ... - Biomeedikum

Create successful ePaper yourself

Delete template?

Save as template?